Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Grönefeld

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Herzschrittmachertherapie & Elektrophysiologie|November 25, 2010
[Antiarrhythmic therapy with β-receptor antagonists]G C Grönefeld, D Bänsch
Pacing and Clinical Electrophysiology : PACE|January 5, 2001
Efficacy and safety of transvenous atrial cardioversion in patients with mitral valve disease and long-standing atrial fibrillationG C Grönefeld, Y G Li, F Bogun, et al.
Journal of Cardiovascular Electrophysiology|November 18, 2000
Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective studyG C Grönefeld, O Mauss, Y G Li, et al.
Der Internist|January 19, 2006
[Pharmacological therapy for ventricular arrhythmias: evidence for current treatment strategies and perspectives for the future]F T Wegener, G C Grönefeld, G Duray, et al.
Pacing and Clinical Electrophysiology : PACE|November 15, 2001
Morphology discrimination: a beat-to-beat algorithm for the discrimination of ventricular from supraventricular tachycardia by implantable cardioverter defibrillatorsG C Grönefeld, B Schulte, S H Hohnloser, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Herzschrittmachertherapie & Elektrophysiologie|November 25, 2010
[Antiarrhythmic therapy with β-receptor antagonists]G C Grönefeld, D Bänsch
Pacing and Clinical Electrophysiology : PACE|January 5, 2001
Efficacy and safety of transvenous atrial cardioversion in patients with mitral valve disease and long-standing atrial fibrillationG C Grönefeld, Y G Li, F Bogun, et al.
Journal of Cardiovascular Electrophysiology|November 18, 2000
Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective studyG C Grönefeld, O Mauss, Y G Li, et al.
Der Internist|January 19, 2006
[Pharmacological therapy for ventricular arrhythmias: evidence for current treatment strategies and perspectives for the future]F T Wegener, G C Grönefeld, G Duray, et al.
Pacing and Clinical Electrophysiology : PACE|November 15, 2001
Morphology discrimination: a beat-to-beat algorithm for the discrimination of ventricular from supraventricular tachycardia by implantable cardioverter defibrillatorsG C Grönefeld, B Schulte, S H Hohnloser, et al.
Pageof 1